𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intravenous Administration of Alendronate Counteracts the In Vivo Effects of Glucocorticoids on Bone Remodeling

✍ Scribed by F. Falcini; S. Trapani; M. Ermini; M. L. Brandi


Publisher
Springer
Year
1996
Tongue
English
Weight
346 KB
Volume
58
Category
Article
ISSN
1432-0827

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effect of alendronate on fracture healin
✍ C. P. Peter; William O. Cook; David M. Nunamaker; Michael T. Provost; J. Gregory πŸ“‚ Article πŸ“… 1996 πŸ› Elsevier Science 🌐 English βš– 634 KB

To examine the effect of alendronate (4-amino-1-hydroxybutylidene bisphosphonate) on fracture repair, the drug was given to mature beagle dogs orogastrically at 2 mg/kg/day for 9 weeks preceding fracture. 16 weeks after fracture, or both before and after fracture (25 weeks). A transverse mid-diaphys

The effect of alendronate (Fosamax?) and
✍ Frenkel, Sally R. ;Jaffe, William L. ;Valle, Craig Della ;Jazrawi, Laith ;Maurer πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 278 KB πŸ‘ 1 views

## Abstract Patients at high risk for osteoporosis and its associated morbidity, including postmenopausal women, are being pharmacologically managed to stabilize and improve bone mass. Alendronate sodium (Fosamaxβ„’) is a commonly used antiresorptive agent effective in osteopenic women for reducing b